Vaccination Principles Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Vaccination Principles. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Vaccination Principles Indian Medical PG Question 1: Mass vaccination is ineffective in inducing 'herd immunity' for:
- A. Poliomyelitis
- B. Tetanus (Correct Answer)
- C. None of the options
- D. Measles
Vaccination Principles Explanation: ***Tetanus (Correct Answer)***
- **Herd immunity** relies on reducing person-to-person transmission, which is not applicable to tetanus as it is acquired through **environmental exposure** (soil contaminated with *Clostridium tetani* spores), not human contact
- Vaccination against tetanus provides **individual protection only** and does not prevent disease spread within a population, making mass vaccination ineffective for herd immunity
- Tetanus is a **non-communicable disease** - immunity in others does not protect unvaccinated individuals
*Poliomyelitis (Incorrect)*
- Mass vaccination for poliomyelitis has been highly effective in establishing **herd immunity**, leading to near-global eradication
- The vaccine prevents viral shedding and breaks the chain of transmission
- High vaccination coverage protects unvaccinated individuals through reduced viral circulation
*Measles (Incorrect)*
- Mass vaccination against measles is extremely effective in inducing **herd immunity** due to its high transmissibility (R₀ = 12-18)
- Requires **~95% vaccination coverage** to maintain herd immunity
- Classic example where high vaccination rates protect vulnerable individuals who cannot be vaccinated
*None of the options (Incorrect)*
- This is incorrect because tetanus is a clear example where mass vaccination does **not** induce herd immunity
- The disease's environmental transmission pattern makes herd immunity irrelevant for disease control
Vaccination Principles Indian Medical PG Question 2: Adverse reactions following whole cell pertussis immunization include:
- A. Fever
- B. Local swelling
- C. Excessive cry
- D. All of the options (Correct Answer)
Vaccination Principles Explanation: ***All of the options***
- **Whole-cell pertussis vaccines** are associated with a range of common, generally self-limiting adverse reactions.
- These include systemic effects like **fever** and irritability, often manifested by excessive crying, as well as local reactions at the injection site.
*Fever*
- **Fever** is a very common systemic adverse reaction following whole-cell pertussis immunization, indicating the body's immune response.
- This reaction typically resolves within 24-48 hours.
*Excessive cry*
- **Excessive crying** (often described as inconsolable crying) for several hours is a known systemic adverse effect of whole-cell pertussis vaccines.
- This symptom usually reflects irritability and discomfort experienced by the infant.
*Local swelling*
- **Local swelling** at the injection site, along with redness and tenderness, is a frequent local adverse reaction to whole-cell pertussis immunization.
- These local reactions are generally mild and self-limiting, resolving within a few days.
Vaccination Principles Indian Medical PG Question 3: Which of the following vaccines is classified as a killed vaccine?
- A. Varicella
- B. BCG
- C. OPV
- D. Meningococcal vaccine (Correct Answer)
Vaccination Principles Explanation: ***Meningococcal vaccine***
- The meningococcal conjugate and polysaccharide vaccines are **killed vaccines**, containing inactivated bacterial components (polysaccharides) that stimulate an immune response.
- They provide protection against *Neisseria meningitidis* and are considered safe for most populations due to their non-live nature.
*Varicella*
- The varicella vaccine is a **live-attenuated vaccine**, meaning it contains a weakened form of the **varicella-zoster virus**.
- This attenuated virus can replicate in the recipient, eliciting a strong and long-lasting immune response, similar to natural infection.
*BCG*
- The **Bacillus Calmette-Guérin (BCG)** vaccine is a **live-attenuated vaccine** used to prevent tuberculosis.
- It contains a weakened strain of **_Mycobacterium bovis_**, which is closely related to *Mycobacterium tuberculosis* but has lost its virulence.
*OPV*
- The **Oral Polio Vaccine (OPV)** is a **live-attenuated vaccine** that contains weakened but live strains of all three poliovirus serotypes.
- It induces strong mucosal immunity in the gut, which is crucial for preventing the wild poliovirus from replicating and spreading.
Vaccination Principles Indian Medical PG Question 4: Assertion: VZV vaccine is live attenuated. Reason: It cannot be given to immunocompromised patients.
- A. Both true, reason doesn't explain assertion
- B. Assertion true, reason false
- C. Assertion false, reason true
- D. Both true, reason explains assertion (Correct Answer)
Vaccination Principles Explanation: ***Both true, reason explains assertion***
- The **VZV (varicella-zoster virus) vaccine** is indeed a **live attenuated vaccine** containing weakened virus - the assertion is **TRUE**
- It **cannot be given to immunocompromised patients** due to risk of vaccine-strain disease - the reason is **TRUE**
- The reason **directly explains the assertion**: BECAUSE the vaccine is live attenuated, it poses infection risk and therefore cannot be used in immunocompromised individuals
- The **causal relationship** is clear: live attenuated nature → contraindication in immunocompromised patients
*Both true, reason doesn't explain assertion*
- While both statements are factually true, this option would only be correct if the reason was unrelated to the assertion
- However, the reason **directly explains WHY** the live attenuated nature is clinically significant
- The contraindication is a **direct consequence** of the vaccine being live attenuated, so the reason does explain the assertion
*Assertion true, reason false*
- The assertion is true (VZV vaccine is live attenuated)
- However, the reason is also **TRUE** - live attenuated vaccines are indeed contraindicated in immunocompromised patients due to risk of disseminated vaccine-strain infection
- Since both statements are true, this option is incorrect
*Assertion false, reason true*
- The assertion is **TRUE**, not false - VZV vaccine (Varivax, Zostavax) is a **live attenuated vaccine** containing the Oka strain
- This option incorrectly claims the assertion is false
- Since the assertion is factually correct, this option cannot be right
Vaccination Principles Indian Medical PG Question 5: All of the following statements about MMR vaccine are true EXCEPT:
- A. All live vaccines without exception are contraindicated in pregnant women (Correct Answer)
- B. MMR is a live vaccine
- C. Adverse events from MMR vaccine include fever (usually 6-12 days following vaccination), rash in 5% of vaccinated persons, arthralgia, aseptic meningitis, lymphadenopathy
- D. Evidence shows that aseptic meningitis is associated with all mumps vaccine strains except the Jeryl Lynn strain
Vaccination Principles Explanation: ***Correct Answer: All live vaccines without exception are contraindicated in pregnant women***
- This statement is **FALSE**, making it the correct answer to this EXCEPT question
- While **most live vaccines are contraindicated in pregnancy** (including MMR), the word **"without exception"** makes this statement incorrect
- **Exceptions exist**: Yellow fever vaccine may be administered during pregnancy if travel to endemic areas is unavoidable and the risk of disease outweighs the theoretical vaccine risk
- The absolute nature of this statement contradicts clinical guidelines that recognize situational exceptions
*True Statement - MMR is a live vaccine*
- **MMR vaccine** contains **live-attenuated viruses** of measles, mumps, and rubella
- This live-attenuated nature produces robust, long-lasting immunity
- Being a live vaccine necessitates contraindications in immunocompromised patients and pregnant women
*True Statement - Adverse events from MMR vaccine*
- **Fever** typically occurs **6-12 days post-vaccination** (not immediately), reflecting viral replication
- **Rash** occurs in approximately **5% of vaccinees**
- Other documented adverse events include **arthralgia** (especially in adult women), **aseptic meningitis** (rare), and **lymphadenopathy**
- These adverse events are far less severe than complications from natural measles, mumps, or rubella infection
*True Statement - Aseptic meningitis and vaccine strains*
- **Urabe** and **Leningrad-Zagreb** mumps vaccine strains have been associated with higher rates of vaccine-associated **aseptic meningitis** (approximately 1 in 100,000 to 1 in 1 million doses)
- The **Jeryl Lynn strain** (used in the United States and many other countries) has **negligible or no association** with aseptic meningitis
- This safety profile makes the Jeryl Lynn strain the preferred mumps component in MMR vaccines
Vaccination Principles Indian Medical PG Question 6: All the following are conjugate vaccines Except
- A. Neisseria meningitidis
- B. Haemophilus influenzae type b
- C. Hepatitis A (Correct Answer)
- D. Pneumococcal
Vaccination Principles Explanation: ***Hepatitis A (Correct Answer)***
- The **Hepatitis A vaccine** is a **killed viral vaccine** (inactivated vaccine), meaning it contains whole hepatitis A virus particles that have been inactivated so they cannot replicate or cause disease.
- It is **NOT a conjugate vaccine** - inactivated vaccines primarily induce a **humoral immune response** without the need for a carrier protein conjugated to a polysaccharide.
- This makes Hepatitis A the exception among the options listed.
*Neisseria meningitidis (Incorrect)*
- The most common vaccines against *Neisseria meningitidis* are **conjugate vaccines**, where the **polysaccharide capsule** is chemically linked to a protein carrier to enhance immunogenicity in infants and young children.
- This conjugation allows for T-cell dependent immunity, leading to better memory responses and protection.
*Haemophilus influenzae type b (Incorrect)*
- The **Haemophilus influenzae type b (Hib) vaccine** is a **conjugate vaccine**, linking the **polysaccharide capsule** of the bacterium to a carrier protein.
- This helps induce a robust T-cell dependent immune response, which is crucial for protecting infants and young children against **invasive Hib disease**.
*Pneumococcal (Incorrect)*
- **Pneumococcal conjugate vaccines** (PCV13, PCV15, PCV20) link the **polysaccharide capsule** to a protein carrier, enhancing immunogenicity and memory, especially in young children.
- While polysaccharide vaccines (PPSV23) also exist, the conjugate forms are the primary vaccines used in routine immunization schedules.
Vaccination Principles Indian Medical PG Question 7: Which immunization is typically given at 6 months of age?
- A. Measles vaccine
- B. DPT vaccine (Correct Answer)
- C. BCG vaccine
- D. None of the options
Vaccination Principles Explanation: **DPT vaccine**
- The DPT (diphtheria, pertussis, and tetanus) vaccine is administered in multiple doses during infancy as part of the primary immunization series.
- At **6 months of age**, the **third dose of DPT** is typically given (following doses at 6 weeks, 10 weeks, and 14 weeks according to the Indian immunization schedule).
- Among the options provided, DPT is the only vaccine routinely administered at 6 months of age.
- This vaccine protects against three serious bacterial infections: **diphtheria**, which can cause breathing problems; **pertussis (whooping cough)**, a severe respiratory illness; and **tetanus**, which causes painful muscle spasms.
*Measles vaccine*
- The measles vaccine (given as part of the **MMR vaccine** or as MR vaccine in India) is typically administered at **9 to 12 months of age** for the first dose, and a second dose between 15-18 months or 4-6 years.
- It is not routinely given at 6 months, as maternal antibodies can interfere with its effectiveness at this younger age.
*BCG vaccine*
- The BCG (Bacillus Calmette-Guérin) vaccine protects against **tuberculosis** and is given at **birth** or in early infancy as a single dose.
- It is not administered at 6 months of age.
*None of the options*
- This option is incorrect because the **DPT vaccine** (third dose) is a standard immunization given at 6 months of age according to the Indian immunization schedule.
- Multiple vaccines are actually given at 6 months (including OPV, Hepatitis B, Hib, PCV), but among the listed options, only DPT is correct.
Vaccination Principles Indian Medical PG Question 8: Which route is the H1N1 live vaccine administered by?
- A. Intramuscular
- B. Intranasal (Correct Answer)
- C. Oral
- D. Subcutaneous
Vaccination Principles Explanation: ***Intranasal***
- The **live attenuated influenza vaccine (LAIV)**, often referred to as the "nasal spray flu vaccine," is administered intranasally.
- This route allows the vaccine to replicate in the **nasal passages**, mimicking natural infection and stimulating a localized immune response.
*Intramuscular*
- The **inactivated influenza vaccine (IIV)**, or the "flu shot," is administered intramuscularly.
- This route delivers the vaccine into the **muscle tissue** to stimulate a systemic immune response without local replication.
*Subcutaneous*
- Subcutaneous administration is used for some vaccines, but it is **not the standard route** for either live or inactivated influenza vaccines.
- This route delivers the vaccine into the **fatty tissue** just under the skin.
*Oral*
- Oral administration is typically used for live vaccines that need to replicate in the **gastrointestinal tract**, such as the rotavirus vaccine.
- It is **not an appropriate route** for influenza vaccines as the virus needs to stimulate respiratory immunity.
Vaccination Principles Indian Medical PG Question 9: What is the schedule of intradermal rabies vaccine?
- A. 2-2-0-1-0-1
- B. 8-4-4-1-0-1
- C. 2-2-2-0-1-1
- D. 2-0-2-0-1-1 (Correct Answer)
Vaccination Principles Explanation: ***2-0-2-0-1-1***
- This schedule represents the **Thai Red Cross (TRC) regimen** for intradermal rabies vaccination that was standard at the time of this exam (2013).
- The numbers indicate the number of vaccine doses administered at different sites: **2 doses on day 0** (bilateral deltoids), **0 doses on day 3**, **2 doses on day 7** (bilateral deltoids), **0 doses on day 14**, **1 dose on day 28**, and **1 dose on day 90**.
- This was the **answer expected for NEET 2013** based on the guidelines prevalent at that time.
- **Note:** Current WHO guidelines (post-2013) recommend the updated 2-2-2-0-1-1 schedule (4-site ID regimen) which includes doses on days 0, 3, 7, and 28.
*2-2-0-1-0-1*
- This schedule is **not a recognized** intradermal rabies vaccination protocol.
- Does not match any standard WHO-approved regimen for intradermal administration.
*2-2-2-0-1-1*
- While this may appear incorrect for the 2013 exam context, this schedule actually represents the **current updated Thai Red Cross (4-site ID) regimen** recommended by WHO in recent guidelines.
- This regimen provides doses on **days 0, 3, 7, 28, and 90**, which is now the preferred intradermal schedule.
- However, for the NEET 2013 exam, the older 2-0-2-0-1-1 schedule was the expected answer.
*8-4-4-1-0-1*
- This schedule is **not a standard regimen** and involves an impractically high number of doses.
- No recognized intradermal rabies protocol uses this many doses on initial days.
- Would be **unnecessary and impractical** for effective post-exposure prophylaxis.
Vaccination Principles Indian Medical PG Question 10: A young male came to the hospital with a clean-cut wound without any bleeding. The patient received a full course of tetanus vaccination 10 years ago. What is the best management for this patient?
- A. Single-dose tetanus toxoid (Correct Answer)
- B. Human tetanus immunoglobulin only
- C. Human tetanus immunoglobulin and a full course of vaccine
- D. No treatment required
Vaccination Principles Explanation: ***Single-dose tetanus toxoid***
- For a **clean-cut wound** in a patient who completed a **primary tetanus vaccination series** and received their last dose more than 5 years ago but less than 10 years ago, a **single booster dose** of tetanus toxoid is recommended. [1]
- A booster ensures continued protection, as vaccine-induced immunity wanes over time, but the prior full course provides a robust anamnestic response with a single dose.
*Human tetanus immunoglobulin and a full course of vaccine*
- This regimen (tetanus immunoglobulin + vaccine) is typically reserved for patients with **unvaccinated status**, an **unknown vaccination history**, or a **severely contaminated wound** (e.g., rusty nail, soil contamination) who have not been fully vaccinated.
- The patient had a **clean-cut wound** and completed a full course of vaccination 10 years ago, making immunoglobulin unnecessary and a full course of vaccine excessive.
*Human tetanus immunoglobulin only*
- Administering **tetanus immunoglobulin alone** is appropriate for immediate, passive immunity in situations where a patient is unvaccinated or has an unknown vaccination status and has a significant risk of tetanus from a contaminated wound. [2]
- This patient has a clean wound and a history of full vaccination, so a booster is sufficient to stimulate active immunity.
*No treatment required*
- While the patient was fully vaccinated 10 years ago, the protection from tetanus vaccination can **wane over time**, especially after 5-10 years.
- A **booster dose** is crucial to maintain adequate protection against tetanus, even for a clean wound, given the 10-year interval since the last dose.
More Vaccination Principles Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
